Allograft rejection and tubulointerstitial fibrosis in human kidney allografts

Interrogation by urinary cell mRNA profiling

Thangamani Muthukumar, John R. Lee, Darshana M. Dadhania, Ruchuang Ding, Vijay K. Sharma, Joseph E. Schwartz, Manikkam Suthanthiran

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Because the kidney allograft has the potential to function as an in-vivo flow cytometer and facilitate the access of immune cells and kidney parenchymal cells in to the urinary space, we hypothesized that mRNA profiling of urinary cells offers a noninvasive means of assessing the kidney allograft status. We overcame the inherent challenges of urinary cell mRNA profiling by developing pre-amplification protocols to compensate for low RNA yield from urinary cells and by developing robust protocols for absolute quantification mRNAs using RT-PCR assays. Armed with these tools, we undertook first single-center studies urinary cell mRNA profiling and then embarked on the multicenter Clinical Trials in Organ Transplantation-04 study of kidney transplant recipients. We report here our discovery and validation of diagnostic and prognostic biomarkers of acute cellular rejection and of interstitial fibrosis and tubular atrophy (IF/TA). Our urinary cell mRNA profiling studies, in addition to demonstrating the feasibility of accurate diagnosis of acute cellular rejection and IF/TA in the kidney allograft, advance mechanistic and potentially targetable biomarkers. Interventional trials, guided by urinary cell mRNA profiles, may lead to personalized immunosuppression in recipients of kidney allografts.

Original languageEnglish
Pages (from-to)145-154
Number of pages10
JournalTransplantation Reviews
Volume28
Issue number3
DOIs
Publication statusPublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Allografts
Fibrosis
Kidney
Messenger RNA
Atrophy
Biomarkers
Organ Transplantation
Immunosuppression
Multicenter Studies
Clinical Trials
RNA
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Transplantation

Cite this

Allograft rejection and tubulointerstitial fibrosis in human kidney allografts : Interrogation by urinary cell mRNA profiling. / Muthukumar, Thangamani; Lee, John R.; Dadhania, Darshana M.; Ding, Ruchuang; Sharma, Vijay K.; Schwartz, Joseph E.; Suthanthiran, Manikkam.

In: Transplantation Reviews, Vol. 28, No. 3, 01.01.2014, p. 145-154.

Research output: Contribution to journalReview article

Muthukumar, Thangamani ; Lee, John R. ; Dadhania, Darshana M. ; Ding, Ruchuang ; Sharma, Vijay K. ; Schwartz, Joseph E. ; Suthanthiran, Manikkam. / Allograft rejection and tubulointerstitial fibrosis in human kidney allografts : Interrogation by urinary cell mRNA profiling. In: Transplantation Reviews. 2014 ; Vol. 28, No. 3. pp. 145-154.
@article{1330c345e0254de4a02c3608e8af0f40,
title = "Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: Interrogation by urinary cell mRNA profiling",
abstract = "Because the kidney allograft has the potential to function as an in-vivo flow cytometer and facilitate the access of immune cells and kidney parenchymal cells in to the urinary space, we hypothesized that mRNA profiling of urinary cells offers a noninvasive means of assessing the kidney allograft status. We overcame the inherent challenges of urinary cell mRNA profiling by developing pre-amplification protocols to compensate for low RNA yield from urinary cells and by developing robust protocols for absolute quantification mRNAs using RT-PCR assays. Armed with these tools, we undertook first single-center studies urinary cell mRNA profiling and then embarked on the multicenter Clinical Trials in Organ Transplantation-04 study of kidney transplant recipients. We report here our discovery and validation of diagnostic and prognostic biomarkers of acute cellular rejection and of interstitial fibrosis and tubular atrophy (IF/TA). Our urinary cell mRNA profiling studies, in addition to demonstrating the feasibility of accurate diagnosis of acute cellular rejection and IF/TA in the kidney allograft, advance mechanistic and potentially targetable biomarkers. Interventional trials, guided by urinary cell mRNA profiles, may lead to personalized immunosuppression in recipients of kidney allografts.",
author = "Thangamani Muthukumar and Lee, {John R.} and Dadhania, {Darshana M.} and Ruchuang Ding and Sharma, {Vijay K.} and Schwartz, {Joseph E.} and Manikkam Suthanthiran",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.trre.2014.05.003",
language = "English",
volume = "28",
pages = "145--154",
journal = "Transplantation Reviews",
issn = "0955-470X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Allograft rejection and tubulointerstitial fibrosis in human kidney allografts

T2 - Interrogation by urinary cell mRNA profiling

AU - Muthukumar, Thangamani

AU - Lee, John R.

AU - Dadhania, Darshana M.

AU - Ding, Ruchuang

AU - Sharma, Vijay K.

AU - Schwartz, Joseph E.

AU - Suthanthiran, Manikkam

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Because the kidney allograft has the potential to function as an in-vivo flow cytometer and facilitate the access of immune cells and kidney parenchymal cells in to the urinary space, we hypothesized that mRNA profiling of urinary cells offers a noninvasive means of assessing the kidney allograft status. We overcame the inherent challenges of urinary cell mRNA profiling by developing pre-amplification protocols to compensate for low RNA yield from urinary cells and by developing robust protocols for absolute quantification mRNAs using RT-PCR assays. Armed with these tools, we undertook first single-center studies urinary cell mRNA profiling and then embarked on the multicenter Clinical Trials in Organ Transplantation-04 study of kidney transplant recipients. We report here our discovery and validation of diagnostic and prognostic biomarkers of acute cellular rejection and of interstitial fibrosis and tubular atrophy (IF/TA). Our urinary cell mRNA profiling studies, in addition to demonstrating the feasibility of accurate diagnosis of acute cellular rejection and IF/TA in the kidney allograft, advance mechanistic and potentially targetable biomarkers. Interventional trials, guided by urinary cell mRNA profiles, may lead to personalized immunosuppression in recipients of kidney allografts.

AB - Because the kidney allograft has the potential to function as an in-vivo flow cytometer and facilitate the access of immune cells and kidney parenchymal cells in to the urinary space, we hypothesized that mRNA profiling of urinary cells offers a noninvasive means of assessing the kidney allograft status. We overcame the inherent challenges of urinary cell mRNA profiling by developing pre-amplification protocols to compensate for low RNA yield from urinary cells and by developing robust protocols for absolute quantification mRNAs using RT-PCR assays. Armed with these tools, we undertook first single-center studies urinary cell mRNA profiling and then embarked on the multicenter Clinical Trials in Organ Transplantation-04 study of kidney transplant recipients. We report here our discovery and validation of diagnostic and prognostic biomarkers of acute cellular rejection and of interstitial fibrosis and tubular atrophy (IF/TA). Our urinary cell mRNA profiling studies, in addition to demonstrating the feasibility of accurate diagnosis of acute cellular rejection and IF/TA in the kidney allograft, advance mechanistic and potentially targetable biomarkers. Interventional trials, guided by urinary cell mRNA profiles, may lead to personalized immunosuppression in recipients of kidney allografts.

UR - http://www.scopus.com/inward/record.url?scp=84903697203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903697203&partnerID=8YFLogxK

U2 - 10.1016/j.trre.2014.05.003

DO - 10.1016/j.trre.2014.05.003

M3 - Review article

VL - 28

SP - 145

EP - 154

JO - Transplantation Reviews

JF - Transplantation Reviews

SN - 0955-470X

IS - 3

ER -